APA

Waldeck S., Rassner M., Keye P., Follo M., Herchenbach D., Endres C., Charlet A., Andrieux G., Salzer U., Boerries M., Duyster J. & von Bubnoff N. (20210201). CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AML. : Molecular oncology.

Chicago

Waldeck Silvia, Rassner Michael, Keye Philip, Follo Marie, Herchenbach Dieter, Endres Cornelia, Charlet Anne, Andrieux Geoffroy, Salzer Ulrich, Boerries Melanie, Duyster Justus and von Bubnoff Nikolas. 20210201. CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AML. : Molecular oncology.

Harvard

Waldeck S., Rassner M., Keye P., Follo M., Herchenbach D., Endres C., Charlet A., Andrieux G., Salzer U., Boerries M., Duyster J. and von Bubnoff N. (20210201). CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AML. : Molecular oncology.

MLA

Waldeck Silvia, Rassner Michael, Keye Philip, Follo Marie, Herchenbach Dieter, Endres Cornelia, Charlet Anne, Andrieux Geoffroy, Salzer Ulrich, Boerries Melanie, Duyster Justus and von Bubnoff Nikolas. CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AML. : Molecular oncology. 20210201.